Reliability and Validity of the Turkish Version of the SCIPI

NCT06990243 | Not Yet Recruiting

• 1 other identifier: 15
• Study Type: observational
• Target: 40
• Locations: 0 countries
• Sites: N/A

Brief Summary

Pain after spinal cord injury (SCI) is common, with the majority of individuals experiencing chronic pain and a significant portion reporting severe pain that interferes with their daily lives. Pain due to SCI is divided into two main groups: nociceptive and neuropathic. Clinical expertise is required for the accurate classification of these types of pain. Existing screening tools are generally evaluated with heterogeneous samples and therefore have limited accuracy in individuals with SCI. To address this deficiency, the Spinal Cord Injury Pain Instrument (SCIPI) was developed to define neuropathic pain in a manner specific to SCI. The SCIPI consists of seven items that assess the characteristics of pain and triggering factors. Although this scale, developed in English, has been translated into different languages, there is no Turkish version. This study aimed to examine the validity and reliability of the Turkish version of the SCIPI.

Conditions

Neuropathic Pain; Spinal Cord Injury

Keywords

Neuropathic pain; Psychometric properties; Spinal cord injury pain instrument

Outcome Measures

Primary Outcomes (3)

• The Spinal Cord Injury Pain Instrument (SCIPI)

  SCIPI was developed by Dr. Martin B. Forchheimer et al. to screen for neuropathic pain after spinal cord injury. It is an interview-based assessment tool designed to screen for neuropathic pain in individuals with SCI. SCIPI defines the pain characteristics of individuals and performs comparative analyses with clinical diagnoses. The validity and reliability properties of SCIPI were evaluated in a preliminary validation study. In this study, the following findings were obtained as a result of comparing the SCIPI with clinical diagnoses: sensitivity: 78%, specificity: 73%, and overall diagnostic accuracy: 76%. It shows that SCIPI is a reliable tool for screening neuropathic pain in individuals with spinal cord injury.

  1 week

• DN4 Questionnaire

  DN4 is a questionnaire developed as a diagnostic tool that can be helpful both in daily practice and in clinical studies. It consists of 4 questions and a total of 10 items, including questions related to sensory complaints and bedside sensory examination findings, applied by the clinician. The first 2 questions are answered according to the patient's complaints, and the last 2 questions are answered according to the examination. The answers to the questions have 2 options as yes and no. Each positive item is given 1 point, and each negative item is given 0 points. The total score is calculated as the sum of 10 items, and the threshold value for neuropathic pain is determined as 4 points.

  1 week

• Visual Analog Scale

  It is the most commonly used parameter to measure pain intensity. It is a self-reported scale consisting of a horizontal or vertical line, usually 10 cm long, with two verbal descriptors indicating the pain level fixed at the end points. The patient is asked to mark the point that best expresses their pain. The VAS value is obtained by considering the cm equivalent of the point they mark. '0' means no pain, '10' means unbearable pain.

  1 week

Interventions

Evaluation Group OTHER

An evaluation form will record the participants' socio-demographic characteristics and information about their disease/treatment. Consciousness and cognitive tests will be performed. Then, pain will be assessed with the Visual Analog Scale, 4-Question Neuropathic Pain Questionnaire,, and the Spinal Cord Injury Pain Instrument (SCIPI).

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Individuals with spinal cord injuries

You may qualify if:

• Having any level of SCI
• Being 18-70 years old
• Being at least one month since the SCI
• Being inpatient rehabilitation or living in the community

You may not qualify if:

• Having major depression
• Having suicidal intent or plans
• Being currently addicted to alcohol or drugs
• Not taking stable doses of psychoactive medications

Sponsors & Collaborators

• Istinye University: lead

MeSH Terms

Conditions

Neuralgia; Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Peripheral Nervous System Diseases; Neuromuscular Diseases; Nervous System Diseases; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Spinal Cord Diseases; Central Nervous System Diseases; Trauma, Nervous System; Wounds and Injuries

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Lecturer

Study Record Dates

• First Submitted: April 19, 2025
• First Posted: May 25, 2025
• Study Start: May 28, 2025
• Primary Completion: June 28, 2025
• Study Completion: July 28, 2025
• Last Updated: May 25, 2025

Record last verified: 2025-05